参考文献
［1］陆再英.内科学［M］.7 版.北京：人民卫生出版社，2008.
［2］李兰娟.传染病学［M］.8 版.北京：人民卫生出版社，2013.
［3］Che-Rung Liua，Li Xia，Po-lin Chan，et al.Prevalence of hepatitis C virus infection among key populations in China：A systematic review［J］.International Journal of Infectious Diseases，2019，80：16-27.
［4］Ming-Lung Yu，Wan-Long Chuang.Treatment of chronic hepatitis C in Asia：when East meets Wes［tJ］.J Gastroenterol Hepatol，2009，24（3）：336-345.
［5］Telem DA，Schiano T，Goldstone R，et al.Factors that predict outcome of abdominal operations in patients with advanced cirrhosi［sJ］.Clin Gastroenterol Hepatol，2010，8（5）：451-457.
［6］Ho YP，Chen YC，Yang C，et al.Outcome prediction for critically ill cirrhotic patients：a comparison of Apache Ⅱand Child-Pugh scoring system［sJ］.J Intensive Care Med，2004，19（2）：105-110.
［7］Hofmann WP，Radle J，Moench C，et al.Prediction of perioperative mortality in patients with advanced liver disease and abdominal surgery by the use of different scoring systems and test［sJ］.Z Gastroenterol，2008，46（11）：1283-1289.
［8］G.edward morgan J，Maged S.Mikhail，Michael J.Murray.Clinical Anesthesiology［M］.4th ed.MacGraw-Hill Companies，2006.
［9］Befeler AS，Palmer DE，Hoffman M，et al.The safety of intra-abdominal surgery in patients with cirrhosis：model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcom［eJ］.Arch Surg，2005，140（7）：650-654.
［10］Tarantino G.Could quantitative liver function tests gain wide acceptance among hepatologists？［J］.World J Gastroenterol，2009，15（28）：3457-3461.
［11］Franzetta M，Raimondo D，Giammanco M，et al.Prognostic factors of cirrhotic patients in extra-hepatic surgery［J］.Minerva Chir，2003，58（4）：541-544.
［12］Pandey CK，Karna ST，Pandey VK，et al.Perioperative risk factors in patients with liver disease undergoing non-hepatic surgery［J］.World J Gastrointest Surg，2012，4（12）：267-274.
［13］Suman A，Carey WD.Assessing the risk of surgery in patients with liver diseas［eJ］.Cleve Clin J Med，2006，73（4）：398-404.
［14］Wiesner R，Edwards E，Freeman R，et al.Model for end-stage liver disease（MELD）and allocation of donor liver［sJ］.Gastroenterology，2003，124（1）：91-96.
［15］Teh SH，Nagorney DM，Stevens SR，et al.Risk factors for mortality after surgery in patients with cirrhosi［sJ］.Gastroenterology，2007，132（4）：1261-1269.
［16］Kim SH，Han YD，Lee JG，et al.MELD-based indices as predictors of mortality in chronic liver disease patients who undergo emergency surgery with general anesthesi［aJ］.J Gastrointest Surg，2011，15（11）：2029-2035.
［17］Neeff H，Mariaskin D，Spangenberg HC，et al.Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis：an analysis of 138 operations in the 2000s using Child and MELD score［sJ］.J Gastrointest Surg，2011，15（1）：1-11.
［18］Fleming MM，Liu F，Zhang Y，et al.Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy［J］.World J Surg，2018，42（10）：3390-3397.
［19］Patch D，Armonis A，Sabin C，et al.Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding［J］.Gut，1999，44（2）：264-269.
［20］Ziser A，Plevak DJ.Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery［J］.Curr Opin Anaesthesiol，2001，14（6）：707-711.
［21］Friel CM，Stack J，Forse A，et al.Laparoscopic cholecystectomy in patients with hepatic cirrhosis：a five-year experience［J］.Gastrointest Surg，1999，3（3）：286-291.
［22］Ji W，Li LT，Wang ZM，et al.A randomized controlled trial of laparoscopic versus open cholecystectomy in patients with cirrhotic portal hypertension［J］.World J Gastroenterol，2005，11（16）：2513-2517.
［23］Puggioni A，Wong LL.A metaanalysis of laparoscopic cholecystectomy in patients with cirrhosis［J］.Am Coll Surg，2003，197（6）：921-926.
［24］Poulsen TL，Thulstrup AM，Sørensen HT，et al.Appendicectomy and perioperative mortality in patients with liver cirrhosi［sJ］.Br J Surg，2000，87（12）：1664-1665.
［25］Al-Azzawi Y，Al-Abboodi Y，Fasullo M，et al.The Morbidity and Mortality of Laparoscopic Appendectomy in Patients with Cirrhosi［sJ］.Clin Med Insights Gastroenterol，2018，11：1-4.
［26］Rahimzadeh P，Safari S，Faiz SH，et al.Anesthesia for patients with liver diseas［eJ］.Hepat Mon，2014，14（7）：e19881.
［27］Nimmo SM，Harrington LS.What is the role of epidural analgesia in abdominal surgery［J］？Contin Educ Anaesth Crit Care Pain，2014，14：224-229.
［28］Cowan RE，Jackson BT，Grainger SL，et al.Effects of anesthetic agents and abdominal surgery on liver blood flow［J］.Hepatology，1991，14（6）：1161-1166.
［29］Nishiyama T，Fujimoto T，Hanaoka K.A comparison of liver function after hepatectomy in cirrhotic patients between sevoflurane and isoflurane in anesthesia with nitrous oxide and epidural block［J］.Anesth Analg，2004，98（4）：990-993.
［30］Keith G.Allman，Iain H.Wilson.Oxford Handbook of Anesthesi［aM］.4th Edition.Oxford University Press，2016.
［31］Lianzhu Wang，Anjun Zhang，Wei Liu，et al.Effects of dexmedetomidine on perioperative stress response，inflammation and immune function in patients with different degrees of liver cirrhosi［sJ］.Exp Ther Med，2018，16（5）：3869-3874.
［32］Sun Y，Yang Z，Tan H.Perioperative nutritional support and fluid therapy in patients with liver disease［sJ］.Hepatobiliary Surg Nutr，2014，3（3）：140-148.
［33］Wiklund RA.Preoperative preparation of patients with advanced liver diseas［eJ］.Critical Care Medicine，2004，32（4）：S106-S115.
［34］Paes-barbosa FC，Ferreira FG，Szutan LA.Hepatectomy preoperative planning［J］.Rev Col Bras Cir，2010，37（5）：370-375.
［35］Amarapurkar PD，Amarapurkar DN.Management of coagulopathy in patients with decompensated liver cirrhosi［sJ］.Int J Hepatol，2011，2011：695470.
［36］Youssef WI，Salazar F，Dasarathy S，et al.Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease：a dual phase study［J］.Am J Gastroenterol，2003，98（6）：1391-1394.
［37］Shah NL，Intagliata NM，Northup PG，et al.Procoagulant therapeutics in liver disease：a critique and clinical rationale［J］.Nat Rev Gastroenterol Hepatol，2014，11（11）：675-682.
［38］Samama CM，Djoudi R，Lecompte T，et al.Perioperative platelet transfusion.Recommendations of the French Health Products Safety Agency（AFSSAPS）2003［J］.Minerva Anestesiol，2006，72（6）：447-452.
［39］Peacock EE Jr.Control of wound healing and scar formation in surgical patient［sJ］.Arch Surg，1981，116：1325-1329.
［40］Strassburg CP，Manns MP.Treatment of autoimmune hepatiti［sJ］.Semin Liver Dis，2009，29：273-285.
［41］Papastergiou V，Burroughs AK，Tsochatzis EA.Prognosis and treatment of patients with acute alcoholic hepatitis［J］.Expert Rev Gastroenterol Hepatol，2014，8：471-486.
［42］郭曲练.临床麻醉学［M］.3 版.北京：人民卫生出版社，2011.
［43］Abid S，Ali S，Baig MA，et al.Is it time to replace propranolol with carvedilol for portal hypertension［J］？World J Gastrointest Endosc，2015，7（5）：532-539.
［44］Ojeda A，Moreno LA.Pain management in patients with liver cirrhosi［sJ］.Gastroenterol Hepatol，2014，37（1）：35-45.
［45］Nusrat S，Khan MS，Fazili J，et al.Cirrhosis and its complications：evidence based treatmen［tJ］.World J Gastroenterol，2014，20（18）：5442-5460.
［46］Chatzizacharias NA，Bradley JA，Harper S，et al.Successful surgical management of ruptured umbilical hernias in cirrhotic patients［J］.World J Gastroenterol，2015，21（10）：3109-3113.
［47］Senousy BE，Draganov PV.Evaluation and management of patients with refractory ascites［J］.World J Gastroenterol，2009，15（1）：67-80.